Application Detail
Status
-Description of Medical Service
ImmunoHistoChemistry (IHC) test for identification of Mismatch Repair Deficiency (dMMR) for access to pembrolizumab in patients with Stage IV CRCDescription of Medical Condition
Stage IV Colorectal Carcinoma (CRC) who are receiving first line (1L) treatmentReason for Application
Amendment to MBS itemMedical Service Type
Co-dependent technologyPrevious Application Number
Not ApplicableAssociated Documentation
Application Form
Application form (PDF 271 KB)
Application form (Word 544 KB)
PICO Confirmation
PICO Confirmation (PDF 582 KB)PICO Confirmation (Word 256 KB)